Inventor · disambiguated record
Alessia Fornoni
Also filed as: FORNONI ALESSIA
6 granted patents·7 pending applications·2 citations·filing 2011–2024
71Inventor score
Top patents by PatentIndex Score
13 records- 0175US2024325372A1Compounds for use in treating kidney disordersHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0270US2023338412A1Method of using cyclodextrinL&F RES LLC·Filed 2022·Application pending·0 cites
- 0366US10980828B2Method of using cyclodextrinL&F RES LLC·Filed 2018·Granted Apr 20, 2021·0 cites·11 claims
- 0465US10183038B2Method for preventing and treating renal diseaseL & F RES LLC·Filed 2015·Granted Jan 22, 2019·1 cites·11 claims
- 0564US2020085810A1Compounds for use in treating kidney disordersHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 0663US10765697B2Method and treating renal diseaseL & F RES LLC·Filed 2018·Granted Sep 8, 2020·0 cites·13 claims
- 0763US2021228616A1Method of using cyclodextrinL&F RES LLC·Filed 2021·Application pending·0 cites
- 0863US2021275514A1Compounds for use in treating kidney disordersHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0961US10195227B2Method of using cyclodextrinL&F HEALTH LLC·Filed 2013·Granted Feb 5, 2019·1 cites·7 claims
- 1043US11344604B2Method for treating kidney disordersUNIV MIAMI·Filed 2019·Granted May 31, 2022·0 cites·3 claims
- 1141US10052345B2Assays, methods and kits for predicting renal disease and personalized treatment strategiesFORNONI ALESSIA·Filed 2011·Granted Aug 21, 2018·0 cites·2 claims
- 1241US2021186930A1Methods of Treating Renal Disease Associated With Chronic Kidney Disease Such as Alport SyndromeUNIV MIAMI·Filed 2019·Application pending·0 cites
- 1341US2014302065A1Soluble urokinase receptor (supar) in diabetic kidney diseaseUNIV MIAMI·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alessia Fornoni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →